Can Pharma Innovation Outpace Global Health Threats?
New developments in Ebola vaccines, cancer research, and ulcerative colitis treatments
Read latest briefing →⚕️ Desk
Health, Medicine, Wellness and healthcare developments
New developments in Ebola vaccines, cancer research, and ulcerative colitis treatments
Read latest briefing →Desk archive
From fertility myths to cancer research breakthroughs, understanding the impact of online information
Recent breakthroughs in health AI, promising treatments for rare diseases, and efforts to improve NHS services signal a positive trend in the healthcare sector.
From Meningitis B to Hunter Syndrome, New Developments in Diagnosis and Treatment
From doctor strikes to aspirin shortages, the UK's health system is under strain
From AI-powered mental health chatbots to human composting, healthcare is evolving
The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, while major pharmaceutical companies like Eli Lilly made significant deals, and health tech companies like Whoop secured substantial investments.
Developments in gene editing, weight loss, and childhood dementia treatment
Experimental vaccine developed in just eight weeks to combat deadly outbreak
New studies and developments in ADHD, HIV prevention, dementia, exercise, and psychiatric medications
The FDA has approved a new medicine from Vera Therapeutics for patients with a type of chronic autoimmune kidney disease.
From crumbling employer-based insurance to advances in fertility treatments and biotech mergers
Ebola outbreak, unaffordable health insurance, and medical misperceptions threaten global health
A review of the UK's social care system and advancements in endometriosis diagnosis
New contract clause aims to ensure timely care for patients with pressing health needs
New study results and regulatory developments in the pharmaceutical industry
As Ukraine's healthcare system faces unprecedented attacks, the global medical community is pushing the boundaries of preventative healthcare with AI-driven "digital twins" and grappling with the ethics of accepting donations from questionable sources.
New initiatives and medical breakthroughs in the UK's National Health Service
Hims & Hers CEO Andrew Dudum addressed increasing scrutiny of compounded GLP-1s, discussing the impact on the company's financials and future plans.
Ebola Outbreak Declared International Emergency, New Cancer Test Brings Hope, and Women's Health Issues Highlighted
New treatments and screenings emerge, but challenges persist in healthcare regulation and affordability
Vaccine policies, outbreaks, and pharma trade deals spark debate and action
World Health Assembly convenes as US imposes travel ban and CDC faces criticism
From prescription drug affordability to the quest for eternal life, the healthcare landscape is evolving rapidly